Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL.
Cancer Immunol Immunother
; 70(12): 3709, 2021 Dec.
Article
em En
| MEDLINE
| ID: mdl-34491408
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article